Country: Australia
Bahasa: Inggeris
Sumber: APVMA (Australian Pesticides and Veterinary Medicines Authority)
FORMALIN; CAMPYLOBACTER FETUS VENEREALIS BIOTYPE INTERMEDIUS SUBT1; CAMPYLOBACTER FETUS (VIBRO FETUS) (REFER ALIASES)
ZOETIS AUSTRALIA PTY LTD
vaccine - Campylobacter fetus
PARENTERAL LIQUID/SOLUTION/SUSPENSION
FORMALIN UNGROUPED Active 2.0 ul/ml; CAMPYLOBACTER FETUS VENEREALIS BIOTYPE INTERMEDIUS SUBT1 VACCINE-MICROBIAL Active 0.0 P; CAMPYLOBACTER FETUS (VIBRO FETUS) (REFER ALIASES) VACCINE-MICROBIAL Active 0.0 Q.S
100mL; 20mL; 250mL; 500mL; 50mL
VM - Veterinary Medicine
ZOETIS AUSTRALIA
CATTLE | BEEF | BOS INDICUS | BOS TAURUS | BOVINE | BUFFALO | BULL | BULLOCK | CALF | COW | DAIRY COW | HEIFER | STEER
IMMUNOTHERAPY
BOVINE VENEREAL CAMPYLOBACTERIOSIS (BVC) | BOVINE VIBRIOSIS
Poison schedule: 0; Withholding period: WITHOLDING PERIODS: Nil TRADE ADVICE: EXPORT SLAUGHTER INTERVAL (ESI): ESI n ot applicable.; Host/pest details: CATTLE: [BOVINE VENEREAL CAMPYLOBACTERIOSIS (BVC)]; Poison schedule: 0; Withholding period: ; Host/pest details: CATTLE: [BOVINE VENEREAL CAMPYLOBACTERIOSIS (BVC)]; For the prevention of bovine venereal campylobacteriosis (vibriosis).This vaccine is not suitable for the immunisation of sheep
Registered
2023-07-01
For Official Use Only E-LABEL APPLICATION (DRAFT) COMPANY NAME: ZOETIS AUSTRALIA PTY LTD PRODUCT NAME: VIBROVAX VACCINE ELABEL APPLICATION NO: DC14-05349425E32 APVMA APPROVAL NO: 52391/101293 PRODUCT NO: 52391 VERSION NO: 2.0 APPLICATION STARTED: 2014-Nov-26 11:20:31 VERSION CREATED: 2015-May-26 14:20:42 STARTED BY: Ziauddin Hashmi PRINTED: 2015-Jul-14 14:55:59 LABEL NAME: VIBROVAX VACCINE SIGNAL HEADINGS: FOR ANIMAL TREATMENT ONLY CONSTITUENT STATEMENTS: Campylobacter fetus subspecies venerealis (biotypes venerealis and intermedius) each 4 mg/mL (as formol culture concentrates) 2 µL/mL Formalin added as an antiseptic CLAIMS: For the prevention of Bovine Venereal Campylobacteriosis (Vibriosis). NET CONTENTS: 20 mL 50 mL 100 mL 250 mL 500 mL DIRECTIONS FOR USE: Read the enclosed leaflet for full instructions DIRECTIONS FOR USE Shake well before use and keep thoroughly mixed during use. For Subcutaneous Use Only RESTRAINTS: N/A CONTRAINDICATIONS: This vaccine is not suitable for the immunisation of sheep. PRECAUTIONS: N/A SIDE EFFECTS: As Vibrovax Vaccine is an oily adjuvant vaccine, there may be some swelling at the site of vaccination, but this will gradually disappear. DOSAGE AND ADMINISTRATION: Dosage and administration RLP APPROVED For Official Use Only Use all product within 12 hours of opening. Contents must be stored in a cooler and left in outer package until immediately before use. Residual vaccine left in the container must be discarded and not retained for future use. Before vaccine is injected, the proposed site of inoculation on the animal's skin may be cleaned by swabbing with cotton-wool soaked in an antiseptic solution, such as methylated spirits. Adult cows and heifers more than 18 months old: previously unvaccinated animals should be given a single dose of 5 mL. Thereafter, give either one dose of 5 mL every two years or one dose of 2 mL annually. Animals should be vaccinated about four to six weeks before the commencement of mating. Heifers less than 18 months old: Two doses of 5 mL. The second Baca dokumen lengkap
PRODUCT NAME: VIBROVAX® VACCINE PAGE: 1 OF 5 This revision issued: December, 2011 MATERIAL SAFETY DATA SHEET Issued by: Pfizer Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER Pfizer Australia Pty Ltd 38-42 Wharf Road West Ryde NSW 2114 Tel: 1800 814 883 Fax: (02) 9850 3399 ____________________________________ PFIZER AUSTRALIA PTY LTD A.B.N. 50 008 422 348 CHEMICAL NATURE: Oil-water emulsion of formol cultures and other ingredients. TRADE NAME: VIBROVAX ® VACCINE PRODUCT USE: For the prevention of vibriosis in cattle. CREATION DATE: DECEMBER, 2004 THIS VERSION ISSUED: DECEMBER, 2011 and is valid for 5 years from this date. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSMP CLASSIFICATION: None allocated. ADG CLASSIFICATION: None allocated. Not a Dangerous Good. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Opaque oil-water emulsion. ODOUR: No data. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S INACTIVATED CULTURES AND TOXOIDS ARE NOT REGARDED AS PATHOGENIC IN HUMANS. SELF INJECTION: IN ALL INSTANCES OF ACCIDENTAL SELF INJECTION CONTACT A DOCTOR AS SOON AS POSSIBLE. FURTHER INFORMATION ON TREATMENT IS AVAILABLE FROM POISONS INFORMATION CENTRE. PHONE 131 126. INHALATION SHORT TERM EXPOSURE: The spray mist may be discomforting to the upper respiratory tract and lungs, and repeated exposure may cause sensi Baca dokumen lengkap